HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

SIRT1 as a Promising Novel Therapeutic Target for Myocardial Ischemia Reperfusion Injury and Cardiometabolic Disease.

AbstractBACKGROUND:
Cardiovascular diseases, especially ischemic heart disease and cardiometabolic disease, remain to be the leading cause of morbidity and mortality worldwide. Despite recent progress in diagnostic and therapeutic approaches, the incidence of cardiovascular disease is still rising. Therefore, alternative favorable treatment is urgently needed to rescue the fast growing numbers of patients.
OBJECTIVE:
Herein we aimed to review the relevant role and explore the possibility of SIRT1 as a promising target for protection of heart from ischemia/reperfusion injury and cardiometabolic diseases.
RESULTS:
The activation of SIRT1 participates in a variety of important metabolic and physiologic processes including stress resistance, metabolism, apoptosis and energy balance in heart ischemia injury and cardiometabolic disease.
CONCLUSION:
Current medication targeting SIRT1 may represent a new therapeutic trend for the prevention of cardiovascular disease that is related to energy balance and metabolism.
AuthorsDong Han, Jinda Wang, Sai Ma, Yundai Chen, Feng Cao
JournalCurrent drug targets (Curr Drug Targets) Vol. 18 Issue 15 Pg. 1746-1753 ( 2017) ISSN: 1873-5592 [Electronic] United Arab Emirates
PMID26122034 (Publication Type: Journal Article, Review)
CopyrightCopyright© Bentham Science Publishers; For any queries, please email at [email protected].
Chemical References
  • Heterocyclic Compounds, 4 or More Rings
  • SRT1720
  • Stilbenes
  • SIRT1 protein, human
  • Sirtuin 1
  • Resveratrol
Topics
  • Animals
  • Apoptosis
  • Disease Models, Animal
  • Heterocyclic Compounds, 4 or More Rings (pharmacology, therapeutic use)
  • Humans
  • Metabolic Diseases (drug therapy, metabolism)
  • Molecular Targeted Therapy
  • Myocardial Ischemia (drug therapy, metabolism)
  • Myocardial Reperfusion Injury (drug therapy, metabolism)
  • Myocytes, Cardiac (cytology)
  • Resveratrol
  • Sirtuin 1 (metabolism)
  • Stilbenes (pharmacology, therapeutic use)
  • Transcriptional Activation (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: